Introducing the new IMAGE Skincare range

Introducing the new IMAGE Skincare range

IMAGE Skincare consistently produces the latest anti-aging, balancing, hydrating and illuminating technologies to further its mission of helping the world to Age Later.
IMAGE Skincare truly cares about skin. All of it, every type, every day. Highly effective, easy-to-use products that help skin defy ageing and harsh environmental effects.
Physicians, aestheticians and spa owners trust IMAGE to keep skin fresh, healthy and youthful looking. Because it works.

 

IMAGE Skincare’s highly effective AGELESS line utilises AHA blends, nutripeptides, retinols, lightening agents and anti-oxidants to produce younger looking skin.

Skin that looks older, photo-damaged, pigmented, dull or tired will be rejuvenated with the use of these innovative skin care products.

This effective regimen helps to treat and prevent fine lines, wrinkles and other signs of aging due to environmental exposures.

The VITAL C product line is ideal for dry/dehydrated, rosacea-prone and sensitive skin due to harsh environmental stressors. A rich blend of natural botanicals creates a soothing and healthy way to improve skin.

A product line high in anti-oxidants for ultimate protection and nutrition.

ORMEDIC,® IMAGE Skincare’s revolutionary product line, is a synthesis of the purest organic ingredients combined with medical effectiveness to achieve clinically-proven results.

The philosophy of ORMEDIC® is to balance the skin’s health with certified organic ingredients, highly potent anti-oxidants and essential botanicals, without the use of chemicals, acids or parabens. Formulated for all skin types to balance, restore and deliver health — the natural way.

An evolution of moisturisers with built-in broad spectrum UVA/UVB sun protection. Medical studies confirm that sun, pollution, stress and smoke are the leading causes of skin cancer and accelerated aging.

Protect your skin daily with an IMAGE moisturiser formulated for your skin type.

Author Info

No Comments

Comments are closed.